| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
108,000,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
5,721,727 |
Avg
Vol: |
2,596,545 |
| 52
Week Range: |
$73.89 - $73.89 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Seiwert Scott |
SVP, Rsearch & Technical Dev. |
• – – |
2010-12-06 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
58,974 |
|
- |
|
| Seiwert Scott |
SVP, Rsearch & Technical Dev. |
• – – |
2010-11-02 |
4 |
B |
$13.27 |
$110,247 |
D/D |
8,308 |
51,974 |
2.74 |
- |
|
| Hodgman John |
SVP-Finance & CFO |
• – – |
2010-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
64,563 |
|
- |
|
| Porter Steven Bryant |
Chief Medical Officer |
• – – |
2010-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
60,957 |
|
- |
|
| Simon Howard Allan |
SVP-Human Resources |
• – – |
2010-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
46,976 |
|
- |
|
| Bradford Williamson Z III |
SVP-Clinical Science |
• – – |
2010-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
69,874 |
|
- |
|
| Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
• – – |
2010-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
60,874 |
|
- |
|
| Welch Daniel G |
Chairman, CEO and President |
• • – |
2010-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
324,517 |
|
- |
|
| Di Nepi Giacomo |
SVP, Managing Director, Europe |
• – – |
2010-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
|
- |
|
| Seiwert Scott |
SVP, Rsearch & Technical Dev. |
• – – |
2010-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
43,666 |
|
- |
|
| Steele Robin Joan |
SVP, GC, Secretary |
• – – |
2010-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
66,908 |
|
- |
|
| Cohen Alan Howard |
SVP, Medical Affairs |
• – – |
2010-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
|
- |
|
| Seiwert Scott |
Officer |
– – – |
2010-05-21 |
144 |
NP |
$0.00 |
$4,065 |
/ |
417 |
0 |
|
- |
|
| Seiwert Scott |
SVP, Rsearch/ Preclinical Dev. |
• – – |
2010-05-20 |
4 |
S |
$9.75 |
$4,066 |
D/D |
(417) |
23,666 |
|
- |
|
| Simon Howard Allan |
Officer |
– – – |
2010-05-19 |
144 |
NP |
$0.00 |
$3,713 |
/ |
356 |
0 |
|
- |
|
| Hodgman John |
Officer |
– – – |
2010-05-19 |
144 |
NP |
$0.00 |
$8,031 |
/ |
770 |
0 |
|
- |
|
| Seiwert Scott |
Officer |
– – – |
2010-05-18 |
144 |
NP |
$0.00 |
$6,693 |
/ |
625 |
0 |
|
- |
|
| Hodgman John |
Officer |
– – – |
2010-05-18 |
144 |
NP |
$0.00 |
$8,246 |
/ |
770 |
0 |
|
- |
|
| Simon Howard Allan |
Officer |
– – – |
2010-05-18 |
144 |
NP |
$0.00 |
$5,783 |
/ |
540 |
0 |
|
- |
|
| Porter Steven Bryant |
Chief Medical Officer |
• – – |
2010-05-18 |
4 |
S |
$10.30 |
$67,141 |
D/D |
(6,506) |
25,957 |
|
- |
|
| Hodgman John |
SVP-Finance & CFO |
• – – |
2010-05-18 |
4 |
S |
$10.50 |
$120,078 |
D/D |
(11,436) |
29,563 |
|
- |
|
| Hodgman John |
SVP-Finance & CFO |
• – – |
2010-05-18 |
4 |
D |
$10.43 |
$8,031 |
D/D |
(770) |
40,999 |
|
- |
|
| Bradford Williamson Z III |
SVP-Clinical Science |
• – – |
2010-05-18 |
4 |
S |
$10.30 |
$65,271 |
D/D |
(6,337) |
25,874 |
|
- |
|
| Armstrong Marianne |
Chief Med. Affairs/Reg. Off. |
• – – |
2010-05-18 |
4 |
S |
$10.34 |
$65,545 |
D/D |
(6,339) |
25,874 |
|
- |
|
| Seiwert Scott |
SVP, Rsearch/ Preclinical Dev. |
• – – |
2010-05-18 |
4 |
S |
$10.63 |
$114,949 |
D/D |
(10,810) |
24,083 |
|
- |
|
772 Records found
|
|
Page 15 of 31 |
|
|
